ANDA 40718, held by Sun Pharma Canada. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40718 (Promethazine Hydrochloride), held by Sun Pharma Canada, was first approved by FDA on Apr 4, 2007, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 4, 2007 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride6.25MG/5ML ยท syrup;oral | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters